...Helen Casey; Natalie Dennehy; Abigail Fraser; Christoph Lees; Carmel M. McEniery; Kayley Scott; Ian B. Wilkinson; Christian Delles The placental syndromes gestational hypertension, preeclampsia and intrauterine growth restriction are associated with an increased cardiovascular risk to the mother...

... as older sedentary individuals with increased cardiovascular risk (SR, n =84, 50% female, 58.7 ± 6.6 years old). The SR group was randomized into a 12-week walking-based HIIT program or control group. We measured protein-bound and free plasma AGEs and dicarbonyls by ultra-performance liquid chromatography...

... and cardioprotective functions of HDLs. © 2019 The Author(s). Published by Portland Press Limited on behalf of the Biochemical Society 2019 apolipoprotein A-I cardiovascular risk high-density lipoprotein metabolic disorders 22 08 2019 18 10 2019 25 10 2019 Correspondence: Kwok...

... ], we will divide the studies on the actions of TRAIL, OPG, and TWEAK into those focusing on non-diabetic and those focusing on diabetic kidney disease. biomarkers cardiovascular risk diabetic kidney disease non-diabetic kidney disease TRAIL and OPG TWEAK The tumor necrosis...

...Andreia Z. Chignalia; Maria Aparecida Oliveira; Victor Debbas; Randal O. Dull; Francisco R.M. Laurindo; Rhian M. Touyz; Maria Helena C. Carvalho; Zuleica B. Fortes; Rita C. Tostes The mechanisms whereby testosterone increases cardiovascular risk are not clarified. However, oxidative stress...

...% of total peripheral blood cells; their numbers vary depending on different factors such as antibody affinity, presence of cardiovascular risk factors, coronary artery disease or chronic heart failure [ 22 ]. For flow cytometric quantification of EPCs, 100 μl of whole blood was incubated during 20 min at 4...

... in a cohort of young adults (mean age 22 years) and their siblings participating in a longitudinal study of cardiovascular risk ( n =370). Insulin sensitivity was determined by euglycaemic insulin clamp. EDD (endothelium-dependent dilation) was determined by flow-mediated dilation using high-resolution...

... 1 2010 © The Authors Journal compilation © 2010 Biochemical Society 2010 cardiovascular risk dyslipidaemia endothelial dysfunction fenofibrate statin Type 2 diabetes In Type 2 diabetes, increased CVD (cardiovascular disease) risk is causally related to atherogenic...

... syndromes and other vascular complications. The principal goal of the present review is to evaluate the role of central BP measurements, principally systolic and pulse pressure, for cardiovascular risk assessment. Recent findings suggest that the pulsatile component of BP (when represented by central pulse...

... population. cardiovascular risk case-control study gene polymorphism myocardial infarction peroxisome-proliferator-activated receptor α (PPARα) MI (myocardial infarction) is considered a complex disease. Its development and progression underlies interactions between environmental and genetic...

...Vance A. Spence; Gwen Kennedy; Jill J. F. Belch; Alexander Hill; Faisel Khan Some of the symptoms reported by people with CFS (chronic fatigue syndrome) are associated with various cardiovascular phenomena. Markers of cardiovascular risk, including inflammation and oxidative stress, have been...

... of assessing arterial elasticity using the DC (distensibility coefficient) measured by TDI, the correlation of this with the DC obtained by other methods and the DC in patients with various degrees of cardiovascular risk. We studied 450 subjects (256 men; age, 51±10 years) with and without risk factors...

... were rigorously assessed by comprehensive transthoracic echocardiographic techniques in 229 patients with Type 2 diabetes. Cardiovascular risk factors and diabetic complications were assessed, and predictors of an abnormal echocardiogram were identified using multivariate logistic regression analysis...

... 2007 6 6 2007 © The Authors Journal compilation © 2007 Biochemical Society 2007 apolipoprotein B (ApoB) coronary heart disease cardiovascular risk familial hypercholesterolaemia low-density lipoprotein cholesterol (LDL-C) protein convertase subtilisin/kexin type 9 gene ( PCSK9...

.... There was no difference in the mean level for LTB 4 production in the three groups (non-A/non-B, 24.9±8.3 ng/10 6 cells; HapA, 22.2±11.9 ng/10 6 cells; HapB, 19.8±4.8 ng/10 6 ; P =0.14). The findings indicate that if either the HapA or the HapB haplotype of ALOX5AP indeed increases cardiovascular risk, then the mechanism...

...% respectively) compared with samples processed after clotting for 30 min. Correspondence: Professor Peter Libby (email [email protected] ). 23 2 2006 2 6 2006 19 7 2006 19 7 2006 The Biochemical Society 2006 assay interference cardiovascular risk CD40...

... the distribution of C-reactive protein (CRP) and other markers of inflammation and their relationships with cardiovascular risk markers and renal disease in a remote Australian Aboriginal community. The study included 237 adults (58% of the adult population) in a remote Aboriginal community in the Northern...

... © 1994 The Biochemical Society and the Medical Research Society 1994 body composition body fat cardiovascular risk growth hormone deficiency insulin muscle mass obesity Clinical Science (1994) 87, 201-206 (Printed in Great Britain) 20 I Interactions of body fat and muscle mass...

... patients. 26 3 1993 15 4 1993 © 1993 The Biochemical Society and the Medical Research Society 1993 acute-phase proteins cardiovascular risk hypertriglyceridaemia sialic acid Clinical Science (1993) 85, 219-222 (Printed in Great Britain) Serum sialic acid and acute-phase...

...M. Crook; P. Tutt 1. Serum total sialic acid concentration, recently shown to be a cardiovascular risk factor, and also serum lipid-associated sialic acid concentration were measured in 15 patients with hypertriglyceridaemia (fasting serum triacylglycerol concentration > 2.3 mmol/l) showing...